All Blogs


May 07, 2025

Artificial Intelligence and Machine Learning in Software as a Medical Device (SaMD)


May 06, 2025

Abeona Secures FDA Nod for ZEVASKYN, the First Gene Therapy for RDEB; AbbVie Gains FDA Approval for RINVOQ in Giant Cell Arteritis; Lantern Pharma Advances LP-184 with IND Clearance for TNBC Trial; Ichnos Glenmark Earns FDA Fast Track for ISB 2001 in Multiple Myeloma; Rezolute Wins Breakthrough Therapy Designation for Ersodetug in Tumor-Induced Hypoglycemia


May 05, 2025

Emerging Lupus Nephritis Therapies: Addressing Unmet Needs through Innovation and Mechanistic Targeting


May 02, 2025

New Era in Niemann-Pick Disease: A Comparative Review of MIPLYFFA and AQNEURSA



Apr 30, 2025

Navigating U.S. Tariffs in 2025: Impacts and Strategies for Pharma and Healthcare


Apr 29, 2025

Boston Scientific Pushes Forward Despite $200M Tariff Challenge; Northstrive Biosciences Gets FDA Green Light to Advance EL-22 Obesity Trial; Roche Acts Swiftly to Offset U.S. Tariff Impact with Global Engagements; Verastem Oncology Secures IND Clearance for KRAS G12D Inhibitor Trial; BlackfinBio Gets FDA OK for Phase I/II Trial of BFB-101 in SPG47


Apr 28, 2025

European Lung Cancer Congress (ELCC) 2025 Recap: Advances in Lung Cancer Research and Treatment


Apr 25, 2025

Late-Breaking Science at AAN 2025: Shaping the Future of Neurology